Status:
COMPLETED
LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)
Lead Sponsor:
UCB Pharma
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR)
Eligibility Criteria
Inclusion
- At least 2-year history of Allergic Rhinitis that became symptomatic during the annual grass pollen season.
- A skin test for grass pollens positive:
- Have rhinitis symptoms of such severity that the mean T4SS over the baseline period must be 6.
Exclusion
- Have an associated asthma requiring corticosteroid treatment,
- Have an atopic dermatitis or an urticaria requiring an antihistamine treatment or the administration of oral or topical corticosteroids,
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
729 Patients enrolled
Trial Details
Trial ID
NCT00160589
Start Date
April 1 2005
End Date
September 1 2005
Last Update
December 16 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.